Cover -- Title Page -- Copyright Page -- Contents -- Foreword -- Acknowledgments -- Introduction -- Chapter 1. Biobanks, a Source of Human Samples and Health Data -- 1.1. From the collection of biological samples to the concept of a biobank -- 1.1.1. The biobank concept -- 1.1.2. The first biobank described in the Framingham study -- 1.1.3. Classification of human sample biobanks -- 1.2. Mapping of biobanks -- 1.2.1. The large catalog of European biobanks -- 1.2.2. International biobanks -- 1.2.3. The first results from the megacohorts -- 1.3. Process management in biobanks -- 1.3.1. Sample quality, the priority of biobanks -- 1.3.2. Protection of the human person and personal information -- Chapter 2. Biobanks in the Digital Age and Precision Medicine -- 2.1. Medical imaging biobanks -- 2.1.1. The UK Biobank prospective medical imaging study -- 2.1.2. The Rotterdam prospective imaging study -- 2.1.3. The German National Cohort -- 2.1.4. The European medical imaging biobank project -- 2.2. Radiomics data powered by digital technology -- 2.2.1. A multitude of application areas for biomarkers -- 2.2.2. Biomarkers in quantitative imaging -- 2.2.3. Artificial intelligence for automatic reading of medical images -- 2.3. The infallible traceability of biobank data -- 2.3.1. Automated sample flow, essential for population biobanks -- 2.3.2. Computerized management of clinicobiological annotations -- 2.3.3. International Biobanks of Excellence or Expert Centers -- 2.3.4. The FAIR principles of health data management -- Chapter 3. The Biobanking Lexicon -- 3.1. Accreditation -- 3.2. Anonymization (or de-identification) -- 3.3. ANSM, the French National Agency for the Safety of Medicines and Health Products -- 3.4. Artificial intelligence -- 3.5. BBMRI, the coordinating center for European biobanks.

3.6. BBMRI-ERIC, the research infrastructure for biobanking -- 3.7. BBMRI-ERIC Biobank of Excellence or Expert Center -- 3.8. Biobank information management system (BIMS) -- 3.9. Biobank or biological resource center (BRC) -- 3.10. Biomarker -- 3.11. Biospecimen -- 3.12. Buffy coat -- 3.13. Certification -- 3.14. Clinical biobank -- 3.15. Clinical research or clinical trials -- 3.16. Clinical trial sponsor -- 3.17. CNIL, the French National Commission for Information Technology and Civil Liberties -- 3.18. Cohort and megacohort -- 3.19. Collection of biological samples -- 3.20. Companion test -- 3.21. Computed tomography (CT) -- 3.22. CPP, the French Committee for the Protection of Individuals -- 3.23. Data protection officer (DPO) -- 3.24. Diagnostic biomarker -- 3.25. Digital health or e-health -- 3.26. Electronic case report form (eCRF) -- 3.27. ESBB, the European, Middle Eastern and African Society for Biopreservation and Biobanking -- 3.28. FDA, the US Food and Drug Administration -- 3.29. Formalin-fixed, paraffin-embedded (FFPE) tissue -- 3.30. Free and informed consent -- 3.31. General Data Protection Regulation (GDPR) -- 3.32. Imaging biobank -- 3.33. Imaging biomarker -- 3.34. ISBER, the International Society for Biological and Environmental Repositories -- 3.35. ISO 20387:2018 Biotechnology -- biobanking -- general requirements for biobanking -- 3.36. Laboratory information management system (LIMS) -- 3.37. Liquid biopsy (in oncology) -- 3.38. Machine learning and deep learning -- 3.39. Medical imaging -- 3.40. Microbiota -- 3.41. Monitoring biomarker -- 3.42. MTA or biological material transfer contract -- 3.43. NF S96-900 -- 3.44. Omics -- 3.45. Peripheral blood mononuclear cells (PBMCs) -- 3.46. Personalized or individualized medicine -- 3.47. Pharmacodynamic/response biomarker -- 3.48. Population biobanking.

3.49. Positron emission tomography (PET) -- 3.50. Pre-analytical phase -- 3.51. Precision medicine -- 3.52. Predictive biomarker -- 3.53. Prognostic biomarker -- 3.54. Prospective study/survey -- 3.55. Quality management system (QMS) -- 3.56. QR code -- 3.57. Radiomics -- 3.58. Region of interest or volume of interest (ROI/VOI) -- 3.59. Retrospective study/survey -- 3.60. Standard operating procedures (SOPs) -- 3.61. Stratified medicine -- 3.62. The process of fixation and paraffin embedding -- 3.63. Translational research -- 3.64. Tumor biobank -- Conclusion -- Glossary -- References -- Index -- Other titles from ISTE in Biology and Biomedical Engineering -- EULA.